Intuited delivery of autonomic modulation therapy

Patent metadata

Field	Value
Publication number	US-9370659-B2
Application number	US-201414557707-A
Country	US
Kind code	B2
Filing date	Dec 2, 2014
Priority date	Dec 5, 2013
Publication date	Jun 21, 2016
Grant date	Jun 21, 2016

Abstract

An example of a method embodiment may deliver intermittent neural stimulation (INS) therapy to an autonomic neural target of a patient. The INS therapy includes neural stimulation (NS) ON times alternating with NS OFF times, and includes at least one NS burst of NS pulses during each of the NS ON times. For a given NS OFF time and subsequent NS ON time, delivering INS therapy may include monitoring a plurality of cardiac cycles during the NS OFF time, using the monitored plurality of cardiac cycles to predict cardiac event timing during the subsequent NS ON time, and controlling delivery of the INS therapy using the predicted cardiac event timing to time NS burst delivery of at least one NS burst for the subsequent NS ON time based on the predicted cardiac event timing.

First claim

What is claimed is:

1. A method, comprising:
delivering intermittent neural stimulation (INS) therapy to an autonomic neural target of a patient, the INS therapy including neural stimulation (NS) ON times alternating with NS OFF times, wherein delivering INS therapy includes delivering at least one NS burst of NS pulses during each of the NS ON times, wherein for a given NS OFF time and subsequent NS ON time, delivering INS therapy includes:
monitoring a plurality of cardiac cycles during the NS OFF time;
using the monitored plurality of cardiac cycles to predict cardiac event timing during the subsequent NS ON time; and
controlling delivery of the INS therapy using the predicted cardiac event timing to time NS burst delivery of at least one NS burst for the subsequent NS ON time based on the predicted cardiac event timing.

2. The method of claim 1 , wherein controlling delivery of the INS therapy includes using the predicted cardiac event timing to time NS burst delivery to deliver NS pulses during at least a portion of a predicted refractory period time during the subsequent ON time.

3. The method of claim 1 , wherein for the given NS OFF time and subsequent NS ON time:
delivering INS therapy includes delivering more than one NS burst during the subsequent NS ON time;
using the monitored plurality of cardiac cycles includes using the monitored plurality of cardiac cycles to predict cardiac event timing for more than one of the plurality of cardiac cycles during the sequent NS ON time; and
controlling delivery of the INS therapy includes using the predicted cardiac event timing for more than one of the plurality of cardiac cycles during the subsequent ON time to time NS burst delivery of more than one NS burst during the subsequent ON time.

4. The method of claim 1 , wherein delivering INS therapy includes:
predicting cardiac event timing in each two or more successive cardiac cycles during the subsequent NS ON time using the monitored plurality of cardiac cycles during the NS OFF time; and
delivering at least one burst of NS burst of NS pulses for each of the two or more successive cardiac cycles based on the cardiac timing.

5. The method of claim 1 , wherein delivering INS therapy includes:
predicting cardiac timing in each of two or more non-successive cardiac cycles during the subsequent NS ON time using the monitored plurality of cardiac cycles during the NS OFF time; and
delivering at least one burst of NS pulses for each of the two or more non-successive cardiac cycles based on the cardiac timing, and not delivering NS pulses during one or more other cardiac cycles between the non-successive cardiac cycles.

6. The method of claim 1 , wherein each of the NS ON times correspond to a respective cardiac event.

7. The method of claim 1 , wherein monitoring the plurality of cardiac cycles during the NS OFF time includes sensing heart sounds to monitor the plurality of cardiac cycles.

8. The method of claim 1 , wherein monitoring the plurality of cardiac cycles during the NS OFF time includes sensing pulse pressure.

9. The method of claim 1 , wherein monitoring the plurality of cardiac cycles during the NS OFF time includes using a wide sense vector to remotely monitor the plurality of cardiac cycles.

10. The method of claim 1 , wherein monitoring the plurality of cardiac cycles during the NS OFF time includes using a cardiac sensing lead to monitor the plurality of cardiac cycles.

11. The method of claim 1 , wherein:
monitoring the plurality of cardiac cycles during the NS OFF time includes determining an average heart rate for two or more cardiac cycles during the NS OFF time; and
using the monitored plurality of cardiac cycles to predict cardiac event timing during the subsequent NS ON time includes using the average heart rate to predict cardiac event timing during the subsequent NS ON time.

12. The method of claim 1 , wherein:
monitoring the plurality of cardiac cycles during the NS OFF time includes determining an average heart rate for four cardiac cycles during the NS OFF time; and
using the monitored plurality of cardiac cycles to predict cardiac event timing during the subsequent NS ON time includes using the average heart rate to predict cardiac event timing during the subsequent NS ON time.

13. The method of claim 1 , wherein delivering INS therapy includes delivering a chronic INS therapy to treat a chronic condition.

14. The method of claim 13 , wherein the chronic INS therapy includes a hypertension therapy.

15. The method of claim 13 , wherein the chronic INS therapy includes a heart failure therapy.

16. The method of claim 1 , wherein the INS therapy includes approximately 10 second NS ON times alternating with approximately 50 second NS OFF times.

17. The method of claim 1 , wherein the INS therapy includes NS ON times within a range of approximately 1 second to 6 seconds, and NS OFF times within a range of approximately 5 seconds to 30 seconds.

18. The method of claim 1 , wherein:
controlling delivery of the INS therapy using the predicted cardiac event timing includes timing delivery of NS pulses during at least a portion of an absolute refractory period, a relative refractory period, or both the absolute and relative refractory period; and
delivering the at least one NS burst of NS pulses during each of the NS ON times includes:
dynamically adjusting, based on a predicted cardiac rate, an NS burst duration, or a number of pulses per NS burst or a pulse-to-pulse interval with the NS burst; or
dynamically adjusting timing for delivering NS pulses in response to a premature ventricular contraction (PVC).

19. A system for delivering neural stimulation to an autonomic neural target of a patient, the system comprising:
a cardiac cycle monitor configured to monitor cardiac cycles;
a neural stimulator configured to deliver neural stimulation to the autonomic neural target; and
a controller configured to control the neural stimulator to deliver intermittent neural stimulation (INS) therapy to the autonomic neural target, the INS therapy including neural stimulation (NS) ON times alternating with NS OFF times, wherein in delivering INS therapy the controller and the neural stimulator cooperate to deliver at least one NS burst of NS pulses during each of the NS ON times;
the controller, the neural stimulator and the cardiac cycle monitor configured to cooperate to implement a process to control NS burst timing where the process comprises:
monitoring a plurality of cardiac cycles during a given NS OFF time;
using the monitored plurality of cardiac cycles during the given NS OFF time to predict cardiac event timing during a subsequent NS ON time; and
controlling delivery of the INS therapy using the predicted cardiac event timing to time NS burst delivery of at least one NS burst for the subsequent NS ON time based on the predicted cardiac event timing.

20. The system of claim 19 , wherein the INS therapy more than one NS burst during the NS ON time, and the process implemented through cooperation of the controller, the neural stimulator and the cardiac cycle monitor includes:
using the monitored plurality of cardiac cycles to determine an average heart rate, and using the average heart rate to predict cardiac timing for more than one cardiac cycle during the subsequent NS ON time; and
using the predicted cardiac timing for the more than one cardiac cycle during the subsequent ON time to time NS burst delivery for each of the more than one cardiac cycle during the subsequ

Assignees

• Cardiac Pacemakers Inc

Inventors

• Franke Manfred
• Ruble Stephen B
• Ternes David J
• Hincapie Ordonez Juan Gabriel
• Hamann Jason J

Classifications

• A61N1/36117

  for treating hypertension · CPC title

• A61N1/36175

  Pulse width or duty cycle · CPC title

• A61N1/36114 Primary

  Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362) · CPC title

• A61N1/36178

  Burst or pulse train parameters · CPC title